Related Experiment Video
Updated: Apr 15, 2026

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
Published on: February 16, 2024
Autoimmune Gastritis and Gastric Cancer Risk: Endoscopic and Histopathological Outcomes
Laura Moreu1, Irina Luzko1,2,3,4, Joan Llach2,3,4
1Facultat de Medicina i Ciències de la Salud, Universitat de Barcelona (UB), 08036 Barcelona, Spain.
Autoimmune gastritis (AIG) surveillance is crucial, detecting advanced premalignant lesions in 15.7% and gastric cancer in 5.7% of patients. Older age increases risk, while female sex may offer protection.
Area of Science:
- Gastroenterology
- Immunology
- Oncology
Background:
- Autoimmune gastritis (AIG) is a chronic condition causing stomach atrophy and increasing risks for gastric cancer and neuroendocrine tumors.
- Diagnosis is challenging due to long asymptomatic periods and varied symptoms.
Purpose of the Study:
- To determine the prevalence of gastric cancer and advanced premalignant lesions in AIG patients.
- To identify risk factors for worse endoscopic outcomes in AIG.
Main Methods:
- Retrospective observational study of 70 AIG patients (2006-2024) at Hospital Clínic de Barcelona.
- Patients identified via autoantibodies; data analyzed for clinical, serological, endoscopic, and histological factors.
- Logistic regression used to evaluate risk factors for advanced neoplastic findings.
Main Results:
- 15.7% of patients had advanced premalignant lesions (dysplasia); 5.7% had gastric cancer.
- Atrophy and intestinal metaplasia were highly prevalent (98.6% and 74.3%).
- Older age at diagnosis increased risk (OR=1.06), while female sex decreased risk (OR=0.24).
Conclusions:
- Endoscopic surveillance is vital for early detection of premalignant lesions in AIG.
- Age and sex may inform future risk stratification models for AIG.
- Complexity of AIG progression necessitates individualized follow-up protocols due to limited predictors.
Related Concept Videos
Gastritis-I: Introduction and Types
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Barrett Esophagus-I: Introduction
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Barrett Esophagus-II: Clinical Manifestations and Management
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
